Low Omega-3 Levels Linked to Higher Depression Risk During Interferon Therapy
A higher ratio of arachidonic acid to omega-3 fatty acids at baseline predicted greater risk of developing depression during interferon-alpha treatment.
A growing library of the omega-3 research we're following — summarized and categorized so you can find what matters to you.
A higher ratio of arachidonic acid to omega-3 fatty acids at baseline predicted greater risk of developing depression during interferon-alpha treatment.
In two small trials, daily krill oil supplementation was linked to reduced skin water loss and improved hydration and elasticity compared to placebo, with effects tracking omega-3 blood levels.
Across 58 studies, at least 1,000-1,500 mg/day of EPA plus DHA as triglycerides for 12+ weeks was the lowest dose consistently shown to raise the omega-3 index to recommended levels.
Adults with red blood cell fatty acid patterns rich in long-chain omega-3s had about 26% lower odds of obesity and 27% lower odds of fatty liver disease.
Vegans had markedly lower omega-3 index scores and higher rates of vitamin D and iodine insufficiency compared to vegetarians and omnivores.
Teens taking a daily algae-derived omega-3 blend for 16 weeks showed better word recall and faster attention task reaction times than those on placebo.